Oneview Healthcare shares rise nearly 90pc following a Samsung distribution agreement
Health & Biotech
Health & Biotech
Link copied to
It enables virtual rounds, interpretation services and even visitations — allowing patients to call friends and family. The solution can be rapidly deployed including (but not limited to) COVID-19 responses.
Samsung, specifically the American arm of its IT division (Samsung SDS America), will distribute Oneview’s Cloud Start Product across the United States.
It will mean that Cloud Start can run exclusively on Samsung tablets and therefore it will be easier for new clientele to get started with a more streamlined procurement and implementation process.
Both companies hailed the deal as one that would achieve more efficient healthcare outcomes for healthcare patients.
“Our distribution partnership with Oneview Healthcare enables us to deliver a more cost-effective and impactful solution, allowing caregivers to work efficiently while providing a connected experience for patients,” said Samsung SDS America executive Mingu Lee.
Oneview’s CEO, James Fittler, also said it was a unique opportunity for his company and the market generally.
“Our move to the cloud accelerates speed to market and opens new possibilities for distribution, making it faster, easier and lower-cost for end customers to benefit from the digital platform at the bedside,” he said.
“Never has this need been so apparent.”
It’s not the first time Samsung has given a welcome boost to an ASX small cap. Last June, the global electronics giant teamed up with Wireless technology company Etherstack (ASX:ESK) to integrate Etherstack’s radio technologies into its own mobile networks.
Shares in Oneview Healthcare have lagged since COVID-19 hit, despite many of its telehealth peers gaining.
But today its shares rose nearly 90 per cent making it one of the ASX’s biggest winners in early trade.